• PDF: Delivered by email usually within 48 UK business hours.

Gen-Probe Incorporated Market Share Analysis

  • Publication Date:December 2011
  • Publisher:GlobalData
  • Product Type: Report
  • Pages:179

Gen-Probe Incorporated Market Share Analysis

Summary

GlobalData's new report, 'Gen-Probe Incorporated Market Share Analysis' provides in-depth information on Gen-Probe Incorporated's market position in the different medical equipment markets it operates in. The report provides Gen-Probe Incorporated market share information in two key market categories - Infectious Immunology and Genetic Testing. The report also provides data and information on the overall competitive landscape of the markets, the company operates in. The report is supplemented with global corporate-level profile with information on the company's business segments, major products and services, competitors, locations and subsidiaries, financial deals and other key developments.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

  • Global company shares (in Revenues) information for the key markets Gen-Probe Incorporated operates in - In Vitro Diagnostics.
  • Gen-Probe Incorporated's company shares (in Revenues) information for all the key countries the company has presence in - Japan, Australia, China, India, United Kingdom, Italy, Spain, Germany, France, United States, Canada and Brazil.
  • Gen-Probe Incorporated's company shares (in Revenues) information for all the key market categories the company has presence in - Infectious Immunology and Genetic Testing.
  • All the key data-points are for 2010 and cover all the key regions - North America, Asia-Pacific, Europe, Middle East and Africa and South and Central America.
  • Global corporate-level profile with information on the company's business segments, major products and services, competitors, and locations and subsidiaries.
  • The company profile is also supplemented with a SWOT Analysis with in-depth information and analysis of the company's value proposition and the business climate it operates in..
  • Comprehensive coverage of the latest financial deals involving the company and its subsidiaries.

Reasons to buy

  • Develop sales and marketing strategies by identifying who-stands-where in the markets, Gen-Probe Incorporated operates in.
  • Plan your competition strategies by identifying the company's shares in the markets and geographic regions it operates in.
  • Design your own inorganic growth and business-collaboration strategies by understanding the financial deals your competitors are involved in.
  • Advance your understanding of the competitive landscape and the competitors by leveraging on the data and information provided in the report.
  • Support your overall business strategies by leveraging on the key data and information provided in the report, which includes but not limited to Gen-Probe Incorporated's market positions.
  • 1 Table of Contents
    • 1.1 List of Tables
    • 1.2 List of Figures
  • 2 Introduction
    • 2.1 What Is This Report About?
  • 3 Definitions of Markets/Categories Covered
    • 3.1 In Vitro Diagnostics
      • 3.1.1 Genetic Testing
      • 3.1.2 Infectious Immunology
  • 4 Company Snapshot
    • 4.1 Key Information
    • 4.2 Company Overview
    • 4.3 Financial Performance
    • 4.4 SWOT Snapshot
  • 5 Business Description
    • 5.1 Business Overview
    • 5.2 Molecular Diagnostics Products
      • 5.2.1 Overview
      • 5.2.2 Financials
      • 5.2.3 Market View
    • 5.3 Major Products and Services
      • 5.3.1 Overview
  • 6 History
  • 7 SWOT Analysis
    • 7.1 Overview
    • 7.2 Gen-Probe Incorporated Strengths
      • 7.2.1 Core Technologies
      • 7.2.2 Strong Growth in Top and Bottom Line
      • 7.2.3 Broad Product Portfolio
    • 7.3 Gen-Probe Incorporated Weaknesses
      • 7.3.1 Over-dependence on the North American Market
      • 7.3.2 Decline in Liquidity Ratios
      • 7.3.3 Reliance on Third Party Manufacturers
      • 7.3.4 Dependence on Distributors
    • 7.4 Gen-Probe Incorporated Opportunities
      • 7.4.1 Robust Product Pipeline
      • 7.4.2 Strategic Acquisitions
      • 7.4.3 Market Growth in Emerging Economies
      • 7.4.4 Growing Molecular Diagnostics Market
      • 7.4.5 Market Potential: Cancer
      • 7.4.6 Market Opportunity - Infectious Diseases
    • 7.5 Gen-Probe Incorporated Threats
      • 7.5.1 Use of Biological and Harmful Materials
      • 7.5.2 Competitive Landscape
      • 7.5.3 Stringent Government Regulations
      • 7.5.4 Changing Diagnostic Market Conditions
  • 8 Competitors
  • 9 Competitive Landscape
    • 9.1 In Vitro Diagnostics, Global, Market Share (%), 2010
  • 10 Gen-Probe Incorporated Medical Equipment Market Share Analysis
    • 10.1 Gen-Probe Incorporated, In Vitro Diagnostics, Global, Market Share (2010)
    • 10.2 Gen-Probe Incorporated, Asia-Pacific, Market Share (2010)
    • 10.3 Gen-Probe Incorporated, Europe, Market Share (2010)
    • 10.4 Gen-Probe Incorporated, Middle East and Africa, Market Share (2010)
    • 10.5 Gen-Probe Incorporated, North America, Market Share (2010)
    • 10.6 Gen-Probe Incorporated, South and Central America, Market Share (2010)
  • 11 Gen-Probe Incorporated Medical Equipment Market Share Analysis by Category
    • 11.1 Gen-Probe Incorporated, In Vitro Diagnostics, Global, Category Revenue Share (2010)
    • 11.2 Gen-Probe Incorporated, Asia-Pacific, Category Revenue Share (2010)
      • 11.2.1 Gen-Probe Incorporated, Australia, Category Revenue Share (2010)
      • 11.2.2 Gen-Probe Incorporated, China, Category Revenue Share (2010)
      • 11.2.3 Gen-Probe Incorporated, India, Category Revenue Share (2010)
      • 11.2.4 Gen-Probe Incorporated, Japan, Category Revenue Share (2010)
      • 11.2.5 Gen-Probe Incorporated, Other Asia-Pacific, Category Revenue Share (2010)
    • 11.3 Gen-Probe Incorporated, Europe, Category Revenue Share (2010)
      • 11.3.1 Gen-Probe Incorporated, France, Category Revenue Share (2010)
      • 11.3.2 Gen-Probe Incorporated, Germany, Category Revenue Share (2010)
      • 11.3.3 Gen-Probe Incorporated, Italy, Category Revenue Share (2010)
      • 11.3.4 Gen-Probe Incorporated, Spain, Category Revenue Share (2010)
      • 11.3.5 Gen-Probe Incorporated, United Kingdom, Category Revenue Share (2010)
      • 11.3.6 Gen-Probe Incorporated, Other Europe, Category Revenue Share (2010)
    • 11.4 Gen-Probe Incorporated, Middle East and Africa, Category Revenue Share (2010)
    • 11.5 Gen-Probe Incorporated, North America, Category Revenue Share (2010)
      • 11.5.1 Gen-Probe Incorporated, Canada, Category Revenue Share (2010)
      • 11.5.2 Gen-Probe Incorporated, United States, Category Revenue Share (2010)
    • 11.6 Gen-Probe Incorporated, South and Central America, Category Revenue Share (2010)
      • 11.6.1 Gen-Probe Incorporated, Brazil, Category Revenue Share (2010)
      • 11.6.2 Gen-Probe Incorporated, Other South and Central America, Category Revenue Share (2010)
  • 12 Key Employees
  • 13 Key Employee Biographies
  • 14 Locations And Subsidiaries
    • 14.1 Head Office
    • 14.2 Other Locations & Subsidiaries
  • 15 Financial Deals Landscape
    • 15.1 Gen-Probe Incorporated, Deals Volume Summary, 2006 to YTD 2011
  • 16 Gen-Probe Incorporated, Deals Summary By Region, 2006 to YTD 2011
  • 17 Gen-Probe Incorporated Detailed Deal Summary
    • 17.1 Venture Financing
      • 17.1.1 Roka Bioscience Secures $20 Million In Series C Financing
      • 17.1.2 Pacific Biosciences Secures Additional $59 Million In Series F Round Of Financing
      • 17.1.3 Molecular Profiling Raises $7.5 Million In Series B Round Of Financing
    • 17.2 Private Equity
      • 17.2.1 The Riverside Company Acquires GTI Diagnostics
    • 17.3 Partnerships
      • 17.3.1 Xceed Molecular Enters Into Licensing Agreement With Gen-Probe
      • 17.3.2 Tepnel Extends Licensing Agreement With Luminex
      • 17.3.3 Gen-Probe Enters Into Licensing Agreement With University of Michigan
      • 17.3.4 Gen-Probe Enters Into Licensing Agreement With AdnaGen
      • 17.3.5 Transasia Enters Into Distribution Agreement With Gen-Probe
      • 17.3.6 Life Technologies Enters Into An Agreement With Gen-Probe
      • 17.3.7 Tepnel Life Sciences Enters Into An Agreement With SoftGenetics
      • 17.3.8 STRATEC Biomedical Enters Into Co-Development Agreement With Gen-Probe
      • 17.3.9 Millipore Signs An Agreement With Gen-Probe
      • 17.3.10 Gen-Probe Signs An Agreement With 3M Company
      • 17.3.11 Gen-Probe Signs An Agreement With 3M
      • 17.3.12 Gen-Probe Enters Into Co-Development Agreement With Qualigen
      • 17.3.13 Gen-Probe Signs An Agreement With Molecular Profiling Institute
      • 17.3.14 Gen-Probe Enters Into An Agreement With Millipore
      • 17.3.15 Tepnel Life Sciences Enters Into Licensing Agreement With Abcam
      • 17.3.16 Gen-Probe Enters Into Licensing Agreement With bioMerieux
      • 17.3.17 Gen-Probe Enters Into An Agreement With bioMerieux
      • 17.3.18 Gen-Probe Enters Into An Agreement With Corixa
    • 17.4 Equity Offering
      • 17.4.1 DiagnoCure Completes Private Placement Of $5 Million
    • 17.5 Acquisition
      • 17.5.1 Gen-Probe Acquires GTI Diagnostics
      • 17.5.2 Gen-Probe Completes Acquisition Of Prodesse
      • 17.5.3 Gen-Probe Acquires Tepnel Life Sciences
  • 18 Recent Developments
    • 18.1 Strategy And Business Planning
      • 18.1.1 Jan 27, 2009: Novartis And Gen-Probe Agree To Extend And Expand Blood Screening Collaboration
      • 18.1.2 Jun 17, 2008: 3M Ends Staph-Screening Partnership With Gen-Probe
      • 18.1.3 Apr 30, 2007: Gen-Probe And 3M Collaborate To Develop Rapid Molecular Tests
    • 18.2 Financial Announcements
      • 18.2.1 Nov 02, 2011: Gen-Probe Reports Revenues Of $139.1m In Q3 2011
      • 18.2.2 Jul 28, 2011: Gen-Probe Reports Total Revenues Of $135.9m In Q2 2011
      • 18.2.3 Apr 28, 2011: Gen-Probe Reports Net Income Of $23.2 Million In Q1 2011
      • 18.2.4 Feb 15, 2011: Gen-Probe Reports Total Revenues Of $543.3m In 2010
      • 18.2.5 Oct 28, 2010: Gen-Probe Reports Net Income Of $27.40 Million In Q3 2010
      • 18.2.6 Jul 29, 2010: Gen-Probe Reports Net Income Of $28.11 Million In Q2 2010
      • 18.2.7 Apr 29, 2010: Gen-Probe Reports Net Income Of $24.2 Million In Q1 2010
      • 18.2.8 Feb 18, 2010: Gen-Probe Reports Net Income Of $91.7 Million In 2009
      • 18.2.9 Oct 29, 2009: Gen-Probe Reports Net Income Of $22.2 Million In Q3 2009
      • 18.2.10 Jul 30, 2009: Gen-Probe Reports Total Revenues Of $120.5 Million In Q2 2009
      • 18.2.11 Apr 30, 2009: Gen-Probe Reports Net Income Of $25.7 Million For Q1 2009
      • 18.2.12 Feb 17, 2009: Gen-Probe Reports 2008 Results
      • 18.2.13 Oct 30, 2008: Gen-Probe Reports 3Q 2008 Results
      • 18.2.14 Jul 31, 2008: Gen-Probe Declares 2Q 2008 Results
      • 18.2.15 Apr 28, 2008: Gen-Probe Declares Q1 2008 Results
      • 18.2.16 Apr 10, 2008: Gen-Probe To Declare Q1 2008 Results
      • 18.2.17 Feb 13, 2008: Gen-Probe Reports 2007 Results
      • 18.2.18 Oct 30, 2007: Gen-Probe Reports Q3 2007 Results
      • 18.2.19 Aug 01, 2007: Gen-Probe Declares Q2 2007 Results
      • 18.2.20 May 01, 2007: Gen-Probe Declares Q1 2007 Results
      • 18.2.21 Feb 13, 2007: Gen-Probe Declares Q4 2006 Results
      • 18.2.22 Feb 13, 2007: Gen-Probe Declares Q4 2007 Results
    • 18.3 Research And Development
      • 18.3.1 Jul 13, 2011: New Research Demonstrates High Prevalence Of STD Caused By Trichomonas Vaginalis And Potential Of New Molecular Test To Improve Detection: Gen-Probe
    • 18.4 Corporate Communications
      • 18.4.1 Nov 15, 2011: Gen-Probe Announces Retirement Of Hank Nordhoff As Chairman
      • 18.4.2 Sep 20, 2010: Gen-Probe Elects Patrick J. Sullivan To Board
      • 18.4.3 Mar 22, 2010: Gen-Probe Appoints Brian McNamee To The Board
      • 18.4.4 May 18, 2009: Gen-Probe Appoints Carl Hull As CEO
      • 18.4.5 Mar 23, 2009: Gen-Probe Elects Carl Hull As CEO
      • 18.4.6 Feb 03, 2009: Gen-Probe Appoints SVP, Research And Development
      • 18.4.7 Jan 13, 2009: Gen-Probe Appoints Senior Vice President
      • 18.4.8 May 19, 2008: Gen-Probe Elects New Board Member
      • 18.4.9 Feb 11, 2008: Gen-Probe Appoints President
      • 18.4.10 Feb 11, 2008: Gen-Probe Appoints COO
      • 18.4.11 Nov 19, 2007: Gen-Probe Appoints VP, Operations
      • 18.4.12 Sep 20, 2007: Gen-Probe Elects New Board Member
      • 18.4.13 Feb 13, 2007: Gen-Probe COO To Join
    • 18.5 Legal and Regulatory
      • 18.5.1 Feb 16, 2010: Genetic Technologies Files Patent Infringement Suit Against Nine Parties In The US
      • 18.5.2 Oct 21, 2009: Gen-Probe Files Patent Lawsuit Against BD
    • 18.6 Product News
      • 18.6.1 Oct 31, 2011: Gen-Probe Receives FDA Approval For APTIMA HPV Assay To Detect Virus That Causes Cervical Cancer
      • 18.6.2 Aug 29, 2011: FDA Advisory Panel Postpones Review On PROGENSA PCA3 Assay: DiagnoCure
      • 18.6.3 Aug 22, 2011: Gen-Probe Receives Canadian Regulatory Clearance For PANTHER System
      • 18.6.4 Aug 17, 2011: Gen-Probe Receives Canadian Regulatory Approval For PROGENSA PCA3 Assay, New Molecular Urine Test To Help Determine Need For Repeat Prostate Biopsies
      • 18.6.5 May 20, 2011: Gen-Probe Files 510(k) Application With FDA For PANTHER System
      • 18.6.6 Apr 20, 2011: Gen-Probe Receives FDA Approval For APTIMA Trichomonas Vaginalis Assay
      • 18.6.7 Nov 30, 2010: Gen-Probe Launches PANTHER System In Europe
      • 18.6.8 Sep 21, 2010: Gen-Probe Files US Regulatory Application For PROGENSA PCA3 Assay
      • 18.6.9 Jul 26, 2010: Gen-Probe Receives FDA Approval For Prodesse's ProFAST+ Assay To Identify Three Strains Of Influenza A, Including 2009 H1N1
      • 18.6.10 Jun 30, 2010: Gen-Probe Receives European CE Mark For APTIMA Assay To Detect Trichomonas Vaginalis
      • 18.6.11 Apr 22, 2010: Gen-Probe Announces Study Results Showing PROGENSA PCA3 Assay May Help Predict Outcome Of Initial Prostate Biopsies At EAU Meeting
      • 18.6.12 Mar 08, 2010: PROGENSA PCA3 Assay Determines Need Of Repeat Prostate Biopsy In Prostate Cancer Patients
      • 18.6.13 Oct 29, 2009: FDA Issues Emergency Use Authorization For The Prodesse ProFlu-ST
      • 18.6.14 Aug 27, 2009: Gen-Probe Initiates US Clinical Trial For Its PROGENSA PCA3 Assay For Prostate Cancer Risk
      • 18.6.15 Aug 17, 2009: Gen-Probe Initiates US Clinical Trial For Its APTIMA Trichomonas Vaginalis Assay On The TIGRIS System
      • 18.6.16 Nov 21, 2008: Promising Clinical Data On Gen-Probe's APTIMA HPV Test Presented At Major European Medical Meeting
      • 18.6.17 Aug 13, 2008: FDA Grants Full Approval Of PROCLEIX ULTRIO Blood Screening Assay
      • 18.6.18 May 28, 2008: Gen-Probe Launches In Europe CE-Marked APTIMA HPV Assay For Detection Of Human Papillomavirus
      • 18.6.19 Apr 01, 2008: Gen-Probe Begins US Clinical Study Of Molecular Test For Human Papillomavirus
      • 18.6.20 Mar 19, 2008: New Study Backs Use Of Gene-Based Urine Test In Prostate Cancer
      • 18.6.21 May 24, 2007: FDA Approves Gen-Probe's Automated PROCLEIX TIGRIS System To Test Donated Blood With The PROCLEIX ULTRIO Assay
      • 18.6.22 Apr 30, 2007: 3M, Gen-Probe Form Collaboration To Develop Rapid Molecular Tests To Combat Healthcare-Associated Infections
      • 18.6.23 Mar 29, 2007: Promising Data On Molecular Research Test For Prostate Cancer Published In Peer-Reviewed Journal UROLOGY
      • 18.6.24 Mar 23, 2007: Results From Multi-Center European Study Highlight New Molecular Test To Improve Prostate Cancer Diagnosis
      • 18.6.25 Jan 29, 2007: Gen-Probe Reports Positive Regulatory Progress for PROCLEIX ULTRIO Blood Screening Assay on the TIGRIS System
      • 18.6.26 Nov 22, 2006: New, Highly Specific Gene-Based Test For Prostate Cancer Introduced In Europe
      • 18.6.27 Feb 25, 2005: Gen-Probe Signs Agreement With Roche To Purchase Products For APTIMA Human Papillomavirus Assay
  • 19 Appendix
    • 19.1 Research Methodology
    • 19.2 Secondary Research
    • 19.3 Primary Research
    • 19.4 Models
    • 19.5 Forecasts
    • 19.6 Expert Panels
    • 19.7 GlobalData Consulting
    • 19.8 Currency Conversion
    • 19.9 Contact Us
    • 19.10 Disclaimer
    • 1.1 List of Tables
      • Table 1: Gen-Probe Incorporated, Key Facts, 2010
      • Table 2: Gen-Probe Incorporated, SWOT Analysis, 2010
      • Table 3: In Vitro Diagnostics, Global, Company Share by Revenue ($m), 2010
      • Table 4: Gen-Probe Incorporated, In Vitro Diagnostics, Global, Revenue ($m) and Market Share (%), 2010
      • Table 5: Gen-Probe Incorporated, In Vitro Diagnostics, Asia-Pacific, Revenue ($m) and Market Share (%), 2010
      • Table 6: Gen-Probe Incorporated, In Vitro Diagnostics, Europe, Revenue ($m) and Market Share (%), 2010
      • Table 7: Gen-Probe Incorporated, In Vitro Diagnostics, Middle East and Africa, Revenue ($m) and Market Share (%), 2010
      • Table 8: Gen-Probe Incorporated, In Vitro Diagnostics, North America, Revenue ($m) and Market Share (%), 2010
      • Table 9: Gen-Probe Incorporated, In Vitro Diagnostics, South and Central America, Revenue ($m) and Market Share (%), 2010
      • Table 10: Gen-Probe Incorporated, In Vitro Diagnostics, Global, Revenue ($m) and Market Share (%) by Category, 2010
      • Table 11: Gen-Probe Incorporated, In Vitro Diagnostics, Asia-Pacific, Revenue ($m) and Market Share (%) by Category, 2010
      • Table 12: Gen-Probe Incorporated, In Vitro Diagnostics, Australia, Revenue ($m) and Market Share (%) by Category, 2010
      • Table 13: Gen-Probe Incorporated, In Vitro Diagnostics, China, Revenue ($m) and Market Share (%) by Category, 2010
      • Table 14: Gen-Probe Incorporated, In Vitro Diagnostics, India, Revenue ($m) and Market Share (%) by Category, 2010
      • Table 15: Gen-Probe Incorporated, In Vitro Diagnostics, Japan, Revenue ($m) and Market Share (%) by Category, 2010
      • Table 16: Gen-Probe Incorporated, In Vitro Diagnostics, Other Asia-Pacific, Revenue ($m) and Market Share (%) by Category, 2010
      • Table 17: Gen-Probe Incorporated, In Vitro Diagnostics, Europe, Revenue ($m) and Market Share (%) by Category, 2010
      • Table 18: Gen-Probe Incorporated, In Vitro Diagnostics, France, Revenue ($m) and Market Share (%) by Category, 2010
      • Table 19: Gen-Probe Incorporated, In Vitro Diagnostics, Germany, Revenue ($m) and Market Share (%) by Category, 2010
      • Table 20: Gen-Probe Incorporated, In Vitro Diagnostics, Italy, Revenue ($m) and Market Share (%) by Category, 2010
      • Table 21: Gen-Probe Incorporated, In Vitro Diagnostics, Spain, Revenue ($m) and Market Share (%) by Category, 2010
      • Table 22: Gen-Probe Incorporated, In Vitro Diagnostics, United Kingdom, Revenue ($m) and Market Share (%) by Category, 2010
      • Table 23: Gen-Probe Incorporated, In Vitro Diagnostics, Other Europe, Revenue ($m) and Market Share (%) by Category, 2010
      • Table 24: Gen-Probe Incorporated, In Vitro Diagnostics, Middle East and Africa, Revenue ($m) and Market Share (%) by Category, 2010
      • Table 25: Gen-Probe Incorporated, In Vitro Diagnostics, North America, Revenue ($m) and Market Share (%) by Category, 2010
      • Table 26: Gen-Probe Incorporated, In Vitro Diagnostics, Canada, Revenue ($m) and Market Share (%) by Category, 2010
      • Table 27: Gen-Probe Incorporated, In Vitro Diagnostics, United States, Revenue ($m) and Market Share (%) by Category, 2010
      • Table 28: Gen-Probe Incorporated, In Vitro Diagnostics, South and Central America, Revenue ($m) and Market Share (%) by Category, 2010
      • Table 29: Gen-Probe Incorporated, In Vitro Diagnostics, Brazil, Revenue ($m) and Market Share (%) by Category, 2010
      • Table 30: Gen-Probe Incorporated, In Vitro Diagnostics, Other South and Central America, Revenue ($m) and Market Share (%) by Category, 2010
      • Table 31: Gen-Probe Incorporated, Key Employees
      • Table 32: Gen-Probe Incorporated, Other Locations
      • Table 33: Gen-Probe Incorporated, Subsidiaries
      • Table 34: Gen-Probe Incorporated, Deals Volume Summary, 2006 to YTD 2011
      • Table 35: Gen-Probe Incorporated, Deals Summary By Region, 2006 to YTD 2011
      • Table 36: Gen-Probe Incorporated, Deals Summary, 2006 to YTD 2011
      • Table 37: Roka Bioscience Secures $20 Million In Series C Financing
      • Table 38: Pacific Biosciences Secures Additional $59 Million In Series F Round Of Financing
      • Table 39: Molecular Profiling Raises $7.5 Million In Series B Round Of Financing
      • Table 40: The Riverside Company Acquires GTI Diagnostics
      • Table 41: Xceed Molecular Enters Into Licensing Agreement With Gen-Probe
      • Table 42: Tepnel Extends Licensing Agreement With Luminex
      • Table 43: Gen-Probe Enters Into Licensing Agreement With University of Michigan
      • Table 44: Gen-Probe Enters Into Licensing Agreement With AdnaGen
      • Table 45: Transasia Enters Into Distribution Agreement With Gen-Probe
      • Table 46: Life Technologies Enters Into An Agreement With Gen-Probe
      • Table 47: Tepnel Life Sciences Enters Into An Agreement With SoftGenetics
      • Table 48: STRATEC Biomedical Enters Into Co-Development Agreement With Gen-Probe
      • Table 49: Millipore Signs An Agreement With Gen-Probe
      • Table 50: Gen-Probe Signs An Agreement With 3M Company
      • Table 51: Gen-Probe Signs An Agreement With 3M
      • Table 52: Gen-Probe Enters Into Co-Development Agreement With Qualigen
      • Table 53: Gen-Probe Signs An Agreement With Molecular Profiling Institute
      • Table 54: Gen-Probe Enters Into An Agreement With Millipore
      • Table 55: Tepnel Life Sciences Enters Into Licensing Agreement With Abcam
      • Table 56: Gen-Probe Enters Into Licensing Agreement With bioMerieux
      • Table 57: Gen-Probe Enters Into An Agreement With bioMerieux
      • Table 58: Gen-Probe Enters Into An Agreement With Corixa
      • Table 59: DiagnoCure Completes Private Placement Of $5 Million
      • Table 60: Gen-Probe Acquires GTI Diagnostics
      • Table 61: Gen-Probe Completes Acquisition Of Prodesse
      • Table 62: Gen-Probe Acquires Tepnel Life Sciences
      • Table 63: USD to Local Currency, Average Exchange Rate, 2010
    • 1.2 List of Figures
      • Figure 1: In Vitro Diagnostics, Global, Market Share (%), 2010
      • Figure 2: Gen-Probe Incorporated, In Vitro Diagnostics, Global, Market Share (%), 2010
      • Figure 3: Gen-Probe Incorporated, In Vitro Diagnostics, Asia-Pacific, Market Share (%), 2010
      • Figure 4: Gen-Probe Incorporated, In Vitro Diagnostics, Europe, Market Share (%), 2010
      • Figure 5: Gen-Probe Incorporated, In Vitro Diagnostics, North America, Market Share (%), 2010
      • Figure 6: Gen-Probe Incorporated, In Vitro Diagnostics, South and Central America, Market Share (%), 2010
      • Figure 7: Gen-Probe Incorporated, In Vitro Diagnostics, Global, Category Revenue Share (%), 2010
      • Figure 8: Gen-Probe Incorporated, In Vitro Diagnostics, Global, Market Share (%) by Category, 2010
      • Figure 9: Gen-Probe Incorporated, In Vitro Diagnostics, Asia-Pacific, Category Revenue Share (%), 2010
      • Figure 10: Gen-Probe Incorporated, In Vitro Diagnostics, Asia-Pacific, Market Share (%) by Category, 2010
      • Figure 11: Gen-Probe Incorporated, In Vitro Diagnostics, Australia, Category Revenue Share (%), 2010
      • Figure 12: Gen-Probe Incorporated, In Vitro Diagnostics, Australia, Market Share (%) by Category, 2010
      • Figure 13: Gen-Probe Incorporated, In Vitro Diagnostics, China, Category Revenue Share (%), 2010
      • Figure 14: Gen-Probe Incorporated, In Vitro Diagnostics, China, Market Share (%) by Category, 2010
      • Figure 15: Gen-Probe Incorporated, In Vitro Diagnostics, India, Category Revenue Share (%), 2010
      • Figure 16: Gen-Probe Incorporated, In Vitro Diagnostics, India, Market Share (%) by Category, 2010
      • Figure 17: Gen-Probe Incorporated, In Vitro Diagnostics, Japan, Category Revenue Share (%), 2010
      • Figure 18: Gen-Probe Incorporated, In Vitro Diagnostics, Japan, Market Share (%) by Category, 2010
      • Figure 19: Gen-Probe Incorporated, In Vitro Diagnostics, Other Asia-Pacific, Category Revenue Share (%), 2010
      • Figure 20: Gen-Probe Incorporated, In Vitro Diagnostics, Other Asia-Pacific, Market Share (%) by Category, 2010
      • Figure 21: Gen-Probe Incorporated, In Vitro Diagnostics, Europe, Category Revenue Share (%), 2010
      • Figure 22: Gen-Probe Incorporated, In Vitro Diagnostics, Europe, Market Share (%) by Category, 2010
      • Figure 23: Gen-Probe Incorporated, In Vitro Diagnostics, France, Category Revenue Share (%), 2010
      • Figure 24: Gen-Probe Incorporated, In Vitro Diagnostics, France, Market Share (%) by Category, 2010
      • Figure 25: Gen-Probe Incorporated, In Vitro Diagnostics, Germany, Category Revenue Share (%), 2010
      • Figure 26: Gen-Probe Incorporated, In Vitro Diagnostics, Germany, Market Share (%) by Category, 2010
      • Figure 27: Gen-Probe Incorporated, In Vitro Diagnostics, Italy, Category Revenue Share (%), 2010
      • Figure 28: Gen-Probe Incorporated, In Vitro Diagnostics, Italy, Market Share (%) by Category, 2010
      • Figure 29: Gen-Probe Incorporated, In Vitro Diagnostics, Spain, Category Revenue Share (%), 2010
      • Figure 30: Gen-Probe Incorporated, In Vitro Diagnostics, Spain, Market Share (%) by Category, 2010
      • Figure 31: Gen-Probe Incorporated, In Vitro Diagnostics, United Kingdom, Category Revenue Share (%), 2010
      • Figure 32: Gen-Probe Incorporated, In Vitro Diagnostics, United Kingdom, Market Share (%) by Category, 2010
      • Figure 33: Gen-Probe Incorporated, In Vitro Diagnostics, Other Europe, Category Revenue Share (%), 2010
      • Figure 34: Gen-Probe Incorporated, In Vitro Diagnostics, Other Europe, Market Share (%) by Category, 2010
      • Figure 35: Gen-Probe Incorporated, In Vitro Diagnostics, Middle East and Africa, Category Revenue Share (%), 2010
      • Figure 36: Gen-Probe Incorporated, In Vitro Diagnostics, Middle East and Africa, Market Share (%) by Category, 2010
      • Figure 37: Gen-Probe Incorporated, In Vitro Diagnostics, North America, Category Revenue Share (%), 2010
      • Figure 38: Gen-Probe Incorporated, In Vitro Diagnostics, North America, Market Share (%) by Category, 2010
      • Figure 39: Gen-Probe Incorporated, In Vitro Diagnostics, Canada, Category Revenue Share (%), 2010
      • Figure 40: Gen-Probe Incorporated, In Vitro Diagnostics, Canada, Market Share (%) by Category, 2010
      • Figure 41: Gen-Probe Incorporated, In Vitro Diagnostics, United States, Category Revenue Share (%), 2010
      • Figure 42: Gen-Probe Incorporated, In Vitro Diagnostics, United States, Market Share (%) by Category, 2010
      • Figure 43: Gen-Probe Incorporated, In Vitro Diagnostics, South and Central America, Category Revenue Share (%), 2010
      • Figure 44: Gen-Probe Incorporated, In Vitro Diagnostics, South and Central America, Market Share (%) by Category, 2010
      • Figure 45: Gen-Probe Incorporated, In Vitro Diagnostics, Brazil, Category Revenue Share (%), 2010
      • Figure 46: Gen-Probe Incorporated, In Vitro Diagnostics, Brazil, Market Share (%) by Category, 2010
      • Figure 47: Gen-Probe Incorporated, In Vitro Diagnostics, Other South and Central America, Category Revenue Share (%), 2010
      • Figure 48: Gen-Probe Incorporated, In Vitro Diagnostics, Other South and Central America, Market Share (%) by Category, 2010
      • Figure 49: Gen-Probe Incorporated, Deals Volume Summary, 2006 to YTD 2011
      • Figure 50: Gen-Probe Incorporated, Deals Summary By Region, 2006 to YTD 2011
+44 20 8816 8548

Ask a question about Gen-Probe Incorporated Market Share Analysis

Enter the characters you see in the picture below
Captcha